# FDA Inspection 1045005 - Copernicus Group IRB #1 - March 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/copernicus-group-irb-1/a8686f83-9ae1-47db-84c2-d0a6f64aa9ba
Source feed: FDA_Inspections

> FDA Inspection 1045005 for Copernicus Group IRB #1 on March 12, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1045005
- Company Name: Copernicus Group IRB #1
- Inspection Date: 2018-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 896730 - 2014-09-18](https://www.keypedia.com/records/fda_inspections/copernicus-group-irb-1/50a9e1ee-bcdd-49a1-8d6c-d43c39c6a2e7)
- [FDA Inspection 839971 - 2013-07-18](https://www.keypedia.com/records/fda_inspections/copernicus-group-irb-1/7b56f44f-4e99-4e71-977e-e0811d08d747)
- [FDA Inspection 660246 - 2010-03-08](https://www.keypedia.com/records/fda_inspections/copernicus-group-irb-1/985487e5-0e70-42b9-9f48-14be539766f1)

Company: https://www.keypedia.com/companies/copernicus-group-irb-1/8513f845-48a3-456a-960a-47d848a07b0c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c